Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
![Foto de Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)](/img/uploaded/83840BAFB27885697506E09052EC4858.jpg)
![Foto de Vall d'Hebron Institut de Recerca](/img/noimage_org.png)
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (29)
2024
-
A global action agenda for turning the tide on fatty liver disease
Hepatology, Vol. 79, Núm. 2, pp. 502-523
-
Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort
Critical Care, Vol. 28, Núm. 1
-
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
Schizophrenia Research, Vol. 267, pp. 24-31
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations
Schizophrenia Research, Vol. 267, pp. 534-545
2023
-
Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline
Diabetologia, Vol. 66, Núm. 8, pp. 1557-1575
-
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis
The European respiratory journal, Vol. 61, Núm. 3
-
Ex situ and in situ functionalized Yb/Fe nanoparticles obtained by scanning pulsed laser ablation in liquids: A route to obtain biofunctionalized multiplatform contrast agents for MRI and CT imaging
Powder Technology, Vol. 427
-
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients
Revista de Psiquiatria y Salud Mental
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
-
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis
The Lancet Regional Health - Europe, Vol. 34
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65
-
Scanning pulsed laser ablation in liquids: An alternative route to obtaining biocompatible YbFe nanoparticles as multiplatform contrast agents for combined MRI and CT imaging
Ceramics International, Vol. 49, Núm. 6, pp. 9324-9337
-
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review
Journal of Clinical Medicine, Vol. 12, Núm. 21
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14
2022
-
Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline
Trends in Endocrinology and Metabolism, Vol. 33, Núm. 1, pp. 50-71
-
Host response dysregulations amongst adults hospitalized by influenza A H1N1 virus pneumonia: A prospective multicenter cohort study
European Journal of Internal Medicine, Vol. 104, pp. 89-97
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31